Parker Institute for Cancer Immunotherapy

Parker Institute for Cancer Immunotherapy is a San Francisco-based cancer immunotherapy research institute and strategic venture investor backing biotechnology, life sciences, oncology and pharmaceuticals companies in the United States. It focuses on accelerating cancer therapies through cross-institutional collaboration and has participated in Series A through later-stage venture rounds, including follow-on financings, and has acted as a co-lead investor.